Market revenue in 2023 | USD 78.9 million |
Market revenue in 2030 | USD 121.9 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.35% in 2023. Horizon Databook has segmented the Middle East & Africa clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
Middle East and Africa is the emerging market for clinical trials supply and logistics. Growing demand for personalized healthcare and presence of diverse population in the region, which leads to ease in patient recruitment, are among factors contributing to market growth.
This region offers logistic benefits to European companies, as they are located much closer than Latin American countries. There are more than 12,000 active trials in African and Middle Eastern countries, spearheaded by Kenya, Jordan, Uganda, Israel, & Egypt.
The trend is expected to continue and is anticipated to attract players to this market, thereby contributing to growth of clinical trial supply and logistics market in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa clinical trial supply & logistics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account